This is a critical step toward the initiation of the Phase 1 clinical trial for OCU500—an inhaled mucosal vaccine for COVID-19. The National Institute of Allergy and Infectious Diseases (NIAID ...
Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for OCU500, a novel ...
Chinese biotech CanSino Biologics said in April it was starting trials of an inhaled COVID-19 vaccine, while others looking at nasal or inhaled delivery include Cadogenix, Phage Novo Bio ...
Everything you need to know about getting a Covid-19 vaccination ... there are vaccination updates in your state: The Plan Your Vaccine page will be updated as new information is released from ...
To reduce the spread of COVID-19, many countries have implemented measures such as lockdowns, travel restrictions, mask mandates, and social distancing guidelines. Vaccines have been developed and ...
15, 2024 — A unique influenza vaccine candidate that's inhaled appears safe and could ... live flu virus appears to be safe and ... Nasal COVID-19 Vaccine Halts Transmission, Animal Study ...
24, 2025 — A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical ...
Flu cases and hospitalizations are on the rise among students, according to an article published by UW Health. According to the article, 33% of patients who were tested for influenza tested positive ...